Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > R-107 passed the test for safety

View:

Post by whisky11 on Mar 30, 2022 4:26pm

R-107 passed the test for safety

And effectiveness on large animals, if I remember it right sheep were infected with the virus ant R-107cured them. it is safe and it worked .
This is standard testing, before human you have to taste it on the dogs or sheep, human bodies respond the same way.
So I think everything is OK with R107.

180

Comment

Comment by PTBailey on Mar 30, 2022 6:25pm

I agree, hard to imagine why it would not get approaved once due dilligence is done on part of ethincs committee, and they have been doing that for some time. Also no reason we won't get a NR about the start any day now. Be great to start April with some news.

Comment